Literature DB >> 12502754

Localization of messenger ribonucleic acids for somatostatin receptor subtypes (sstr1-5) in the rat adrenal gland.

Anne-Marie O'Carroll1.   

Abstract

Somatostatin (somatotropin-release inhibitory factor, SRIF) exerts multiple inhibitory actions throughout the central nervous system and the periphery by binding to specific membrane-bound SRIF receptors (sstrs) of which five subtypes (sstr1-5) have now been identified. Individual sstr subtypes have been suggested to mediate selective biological actions of SRIF. Although the adrenal gland is a known target of SRIF action, the sstr subtypes involved in its actions are unclear. This study examined the expression of sstr1-5 in rat adrenal gland by RT-PCR analysis and in situ hybridization (ISH) histochemistry. Using RT-PCR expression combined with Southern blotting, sstr1, -2, -4, and -5 mRNAs were shown in the adrenal gland. ISH histochemistry revealed strong expression of sstr2 mRNA alone localized to the zona glomerulosa of the adrenal cortex and moderate labeling in scattered cells of the adrenal medulla, indicating a possible role for sstr2 in mediating SRIF physiology in this tissue by altering adrenal aldosterone and catecholamine secretion. These data also point to potential roles for sstr subtypes sstr1, -4, and -5 in the adrenal gland.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502754     DOI: 10.1177/002215540305100107

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  4 in total

1.  Transcriptome analysis reveals differentially expressed transcripts in rat adrenal zona glomerulosa and zona fasciculata.

Authors:  Koshiro Nishimoto; Christine S Rigsby; Tao Wang; Kuniaki Mukai; Celso E Gomez-Sanchez; William E Rainey; Tsugio Seki
Journal:  Endocrinology       Date:  2012-02-28       Impact factor: 4.736

2.  Amelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats.

Authors:  Jessica T Y Yue; Michael C Riddell; Elena Burdett; David H Coy; Suad Efendic; Mladen Vranic
Journal:  Diabetes       Date:  2013-02-22       Impact factor: 9.461

3.  Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.

Authors:  Erik Vegt; Annemarie Eek; Wim J G Oyen; Marion de Jong; Martin Gotthardt; Otto C Boerman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-01       Impact factor: 9.236

Review 4.  New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy.

Authors:  Maria Fleseriu; Stephan Petersenn
Journal:  J Neurooncol       Date:  2013-05-15       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.